Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 16.58B P/E 28.42 EPS this Y 1.20% Ern Qtrly Grth -13.20%
Income 577.7M Forward P/E 25.39 EPS next Y 9.40% 50D Avg Chg 4.00%
Sales 3.23B PEG 2.25 EPS past 5Y 11.33% 200D Avg Chg -
Dividend 1.00% Price/Book 5.07 EPS next 5Y 12.00% 52W High Chg -11.00%
Recommedations 2.10 Quick Ratio 2.29 Shares Outstanding 75.70M 52W Low Chg 12.00%
Insider Own 0.19% ROA 7.86% Shares Float 75.52M Beta 0.97
Inst Own 101.04% ROE 16.86% Shares Shorted/Prior 805.98K/805.49K Price 219.41
Gross Margin 44.16% Profit Margin 17.89% Avg. Volume 544,500 Target Price 242.26
Oper. Margin 20.59% Earnings Date Jul 24 Volume 443,871 Change -1.10%
About IDEX Corporation

IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries. The HST segment designs, produces, and distributes precision fluidics positive displacement pumps, powder and liquid processing technologies, drying systems, micro-precision components, pneumatic components and sealing solutions, high performance molded and extruded sealing components, custom mechanical and shaft seals, engineered hygienic mixers and valves, biocompatible medical devices and implantables, air compressors and blowers, optical components and coatings, laboratory and commercial equipment, and precision photonic solutions. This segment serves food and beverage, life sciences, analytical instruments, pharmaceutical and biopharmaceutical, industrial, semiconductor, automotive/transportation, medical/dental, energy, cosmetics, marine, chemical, wastewater and water treatment, research and aerospace/defense markets. The FSDP segment designs, produces, and distributes firefighting pumps, valves and controls, rescue tools, lifting bags, and other components and systems for the fire and rescue industry; engineered stainless steel banding and clamping devices for various industrial and commercial applications; and precision equipment for dispensing, metering, and mixing colorants and paints used in retail and commercial businesses. IDEX Corporation was incorporated in 1987 and is headquartered in Northbrook, Illinois.

IEX Chatroom

User Image Fullratio Posted - 14 hours ago

$IEX debt to equity has decreased by 20% YoY: https://fullratio.com/stocks/nyse-iex/idex

User Image Estimize Posted - 2 days ago

$IEX beats the Estimize EPS Consensus by 10c and misses the Estimize Revenue Consensus by $11.71M. Reports FQ1 earnings of $1.88 EPS an... http://www.estimize.com/iex/fq1-2024?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

User Image DonCorleone77 Posted - 2 days ago

$IEX Idex Corp. sees 2024 adjusted EPS $8.15-$8.45, consensus $8.33 Full year organic sales growth is projected to be 0% to 2% over the prior year, consensus $3.34B.

User Image DonCorleone77 Posted - 2 days ago

$IEX Idex Corp. sees Q2 adjusted EPS $2.00-$2.05, consensus $2.12 Second quarter organic sales are projected to decline 2% to 3% over the prior year period, consensus $841.54M.

User Image DonCorleone77 Posted - 2 days ago

$IEX Idex Corp. reports Q1 adjusted EPS $1.88, consensus $1.76 Reports revenue $801M, consensus $807.02M. "Our IDEX teams delivered solid results in the first quarter, expanding margins within our Fluid & Metering Technologies and Fire & Safety / Diversified Products segments while driving strong cash flow across the company," said Eric D. Ashleman, IDEX Corporation Chief Executive Officer and President. "We experienced an encouraging lift in sequential orders from our core industrial and municipal markets after an extended period of destocking. The Health & Science Technologies segment performed to expectations, but there are differing rates of recovery within its targeted markets. We will deploy resources accordingly to build momentum in these advantaged markets through the remainder of the year. We remain committed to creating superior long-term value by aggressively deploying resources to drive growth both in our current businesses and acquiring new businesses in advantaged markets."

User Image epsguid Posted - 2 days ago

$IEX reported earnings of $1.88, consensus was $1.75, Earnings Whisper was $1.80 via @eWhispers #whisperbeat http://eps.sh/d/iex

User Image Stock_Titan Posted - 2 days ago

$IEX IDEX Reports First Quarter Results and Confirms Full Year Guidance https://www.stocktitan.net/news/IEX/idex-reports-first-quarter-results-and-confirms-full-year-4l4yah5j590i.html

User Image Estimize Posted - 2 days ago

$IEX reports after the close, Estimize Consensus +0.02 EPS and +4.69M Revs compared to WS http://www.estimize.com/iex/fq1-2024?utm_content=prerelease&utm_medium=tweet&utm_source=stocktwits

User Image RahulRanderia Posted - 2 days ago

$IEX trading strong 153 $NIFTY50.NSE $NIFTY500.NSE

User Image Aigner_Andreas Posted - 1 week ago

TF SELL $IEX at 230.49 : 230.83 BigCap 84% Shp 1.88 S 6.64 N 0.9 RSI 36.43% SRSI 0% ADXR 34.56 #stocks #trading #finance #market

User Image aryan_patels Posted - 1 week ago

$IEX $NIFTY50.NSE $NIFTY500.NSE

User Image RahulRanderia Posted - 1 week ago

$IEX is hovering in an Expanding Triangle formation on the daily charts. The stock has bounced from its 100- & 200-day EMA on the daily chart. Momentum Indicator RSI is positive on the daily charts. Therefore, the stock looks good on dips to 146 and can test 167 support is at 130. #Positionalview $NIFTY50.NSE $NIFTY500.NSE

User Image Nelsin Posted - 3 weeks ago

$IEX Buy to Open. Target: $267.89

User Image Stock_Titan Posted - 1 month ago

$IEX IDEX Corporation to Webcast First Quarter 2024 Earnings Call https://www.stocktitan.net/news/IEX/idex-corporation-to-webcast-first-quarter-2024-earnings-7nsbsxr4nzln.html

User Image EmmaRespond Posted - 1 month ago

Investing in the Future with IDEX Corporation - Why You Should Consider Buying the Stock $IEX http://dlvr.it/T4QDJd

User Image TickerDD_com Posted - 1 month ago

From 3/8/2024, looking back across 22 Month-Ends for IEX, Percentage Change of Average Monthly Price had More Positives (55%) while Percentage Change of Average Monthly Volume had More Positives (91%) $IEX #IEX #IEXStock #TickerDD https://www.youtube.com/watch?v=KwjsD0qmHJw

User Image StockInvest_us Posted - 2 months ago

Signal alert: $IEX - GoldenStar https://stockinvest.us/l/85BonEWlDr

User Image StockInvest_us Posted - 2 months ago

Signal alert: $IEX - GoldenStar https://stockinvest.us/l/jeiAjro7cQ

User Image StockInvest_us Posted - 2 months ago

Signal alert: $IEX - GoldenStar https://stockinvest.us/l/QsVNm6nWUq

User Image swingingtech Posted - 2 months ago

$PH, $IEX, $AIT, $FLS https://wallstreetwaves.com/4-industrial-manufacturing-stocks-to-gain-from-enhanced-supply-chains/

User Image Estimize Posted - 2 months ago

$IEX beats the Estimize EPS Consensus by 1c and the Estimize Revenue Consensus by $15.55M. Reports FQ4 earnings of $1.83 EPS and $788.9... http://www.estimize.com/iex/fq4-2023?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

User Image DonCorleone77 Posted - 2 months ago

$IEX Idex Corp. sees FY24 EPS $8.15-$8.45, consensus $8.41 FY24 organic sales growth is projected to be 0% to 2% over the prior year.

User Image DonCorleone77 Posted - 2 months ago

$IEX Idex Corp.sees Q1 EPS $1.70-$1.75, consensus $2.04 Sees Q1 organic sales projected to decline 6% to 7% from the prior year period.

User Image DonCorleone77 Posted - 2 months ago

$IEX Idex Corp. reports Q4 EPS $1.83, consensus $1.78 Reports Q4 revenue $788.9M, consensus $769.1M. "IDEX businesses weathered an unprecedented year of global recalibration, which played out differently across our segments. Our team's agility and core execution capabilities, combined with the quality of our underlying assets, enabled us to deliver strong results in a challenging environment," said Eric D. Ashleman, CEO. "Now, the majority of our end markets are stable, supporting the early stages of focused organic growth to drive our next chapter of outperformance. However, the timing of market recovery within our Life Sciences and Analytical Instrumentation businesses remains uncertain, moderating our overall full year growth outlook. We continue to aggressively pursue inorganic opportunities within advantaged, fast-growing markets, as demonstrated by our purchase of STC Material Solutions in December...."

User Image 1986iamwallstreet Posted - 2 months ago

$IEX IDEX Expects 2024 Organic Sales Growth To Be 0%-2%, Adjusted EPS Of $8.15-$8.45 (Est. $8.41); Q1 Organic Sales To Decline 6%-7%, Adjusted EPS Of $1.70-$1.75 (Est. $2.04)

User Image epsguid Posted - 2 months ago

$IEX reported earnings of $1.83, consensus was $1.78 via @eWhispers #epsbeat http://eps.sh/d/iex

User Image Stock_Titan Posted - 2 months ago

$IEX IDEX Reports Fourth Quarter and Full Year 2023 Results https://www.stocktitan.net/news/IEX/idex-reports-fourth-quarter-and-full-year-2023-jn73d2i3mxpg.html

User Image StockInvest_us Posted - 2 months ago

Signal alert: $IEX - GoldenStar https://stockinvest.us/l/F0b7qMgTCY

User Image Financhill Posted - 2 months ago

$IEX is rated a Sell since January 3, 2024 and is 30% below its median level.

User Image StockInvest_us Posted - 3 months ago

Signal alert: $IEX - GoldenStar https://stockinvest.us/l/XAXqsqUGs0

Analyst Ratings
Baird Outperform Apr 25, 24
Oppenheimer Outperform Apr 18, 24
Citigroup Buy Apr 8, 24
RBC Capital Outperform Mar 21, 24
RBC Capital Outperform Feb 8, 24
Stifel Buy Feb 8, 24
Stifel Hold Jan 23, 24
Stifel Hold Dec 19, 23
Oppenheimer Outperform Oct 19, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Grogan William K SVP, Chief Financial.. SVP, Chief Financial Officer Feb 09 Sell 226.36 3,181 720,051 13,864 02/13/23
Grogan William K SVP, Chief Financial.. SVP, Chief Financial Officer Feb 09 Option 70.11 3,181 223,020 17,045 02/13/23
SATTERTHWAITE LIVINGSTON Director Director Nov 02 Option 50.45 3,075 155,134 16,307 11/02/22
SATTERTHWAITE LIVINGSTON Director Director Nov 02 Sell 222.69 3,075 684,772 13,232 11/02/22
ASHLEMAN ERIC D CEO and President CEO and President Oct 28 Option 84.01 15,848 1,331,390 54,328 11/01/22
ASHLEMAN ERIC D CEO and President CEO and President Oct 28 Sell 218.94 15,848 3,469,761 38,480 11/01/22
Grogan William K SVP, Chief Financial.. SVP, Chief Financial Officer Oct 28 Option 50.45 843 42,529 14,707 11/01/22
Grogan William K SVP, Chief Financial.. SVP, Chief Financial Officer Oct 28 Sell 221.74 843 186,927 13,864 11/01/22
Cade Denise R SVP-General Counsel.. SVP-General Counsel & Corp Sec May 07 Option 75.77 2,165 164,042 7,805 05/07/21
Silvernail Andrew K Chairman and CEO Chairman and CEO Nov 02 Option 125.41 122,426 15,353,445 222,603 11/02/20
Silvernail Andrew K Chairman and CEO Chairman and CEO Nov 02 Sell 169.81 122,426 20,789,159 203,143 11/02/20